Hedge Fund - Harvard Management Co
Abcellera Biologics Inc. (ABCL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q2 (2023-06-30) | $0 | 0% | 0 | $6.82 |
| 2 | 2023 - Q1 (2023-03-31) | $30,952,416 | 3.25% | 4,105,095 | $9.08 |
| 3 | 2022 - Q4 (2022-12-31) | $41,584,612 | 5.15% | 4,105,095 | $11.55 |
| 4 | 2022 - Q3 (2022-09-30) | $40,599,000 | 5.05% | 4,105,095 | $10.97 |
| 5 | 2022 - Q2 (2022-06-30) | $43,719,000 | 5.06% | 4,105,095 | $8.47 |
| 6 | 2022 - Q1 (2022-03-31) | $40,025,000 | 4.04% | 4,105,095 | $9.47 |
| 7 | 2021 - Q4 (2021-12-31) | $58,703,000 | 5.5% | 4,105,095 | $15.18 |
| 8 | 2021 - Q3 (2021-09-30) | $82,266,000 | 4.82% | 4,105,095 | $17.68 |
| 9 | 2021 - Q2 (2021-06-30) | $90,312,000 | 5.19% | 4,105,095 | $27.58 |
| 10 | 2021 - Q1 (2021-03-31) | $139,409,000 | 7.78% | 4,105,095 | $39.83 |
| 11 | 2020 - Q4 (2020-12-31) | $165,189,000 | 8.95% | 4,105,095 | $45.73 |
The displayed share prices are average quarterly stock market prices.